BGM Group Ltd (BGM)

• Market cap: $1.9B
• 1 day: 3.73%
• 5 days: 1.39%
• 1 month: -7.62%
• 3 months: 11.82%
• 6 months: -14.93%
• Year to date: 5.82%
• 1 year: 35.14%
• 5 years: -81.08%
• 10 years: -81.08%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.

Employees: 323